S&P Biotech SPDR (XBI) |
|
76.94 -0.18 (-0.23%)
|
10-14 16:00 |
|
Open: |
77.06 |
Pre. Close: |
77.12 |
|
High:
|
78.05 |
Low:
|
76.41 |
|
Volume:
|
4,085,204 |
Market Cap:
|
7013M |
|
|
|
|
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index.
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
78.134 - 78.582 |
78.582 - 78.987 |
|
Low:
|
75.381 - 75.868 |
75.868 - 76.308 |
|
Close:
|
76.238 - 77.02 |
77.02 - 77.727 |
|
Technical analysis |
as of: 2019-10-14 4:49:44 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 93.28 One year: 98.25 |
| Support: |
Support1: 72.97 Support2: 60.71 |
| Resistance: |
Resistance1: 79.86 Resistance2: 84.12 |
| Pivot: |
76.57 |
| Moving Average: |
MA(5): 75.98  MA(20): 78.10
MA(100): 82.46 MA(250): 82.93 |
| MACD: |
MACD(12,26): -1.40 Signal(9): -1.47 |
| Stochastic oscillator: |
%K(14,3): 37.90 %D(3): 29.49 |
| RSI: |
RSI(14): 44.16 |
| 52-week: |
High: 93.87 Low: 64.38 Change(%): -9.4 |
| Average Vol(K): |
3-Month: 469815 10-Days: 588050 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.XBI has closed below upper band by 43.5%. Bollinger Bands are 11.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
|
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE Arca |
| Sector: |
| Industry: |
| Shares Out. (M) |
53.75 |
| Shares Float (M) |
53.75 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
2297 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
Book Value (p.s.)
|
4.500 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-23.7 |
|
Return on Equity (ttm)
|
-19.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
|
|
P/BV
|
17.10 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
0.275 |
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
